Suppr超能文献

基因突变导致 11β-羟化酶缺乏症的诊断、治疗和基因分析。

Diagnosis, treatment and genetic analysis of 11β -hydroxylase deficiency caused by gene mutation.

机构信息

1. Department of Endocrinology and Metabolism, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.

2. Department of Endocrinology and Metabolism, Zhanjiang Central People's Hospital, Zhanjiang 524037, China.

出版信息

Yi Chuan. 2022 Dec 20;44(12):1175-1182. doi: 10.16288/j.yczz.22-115.

Abstract

Congenital adrenal hyperplasia (CAH) is an autosomal recessive hereditary disease, and the 11β- hydroxylase deficiency is the second most common syndrome in different types of CAH. The occurrence of 11β- hydroxylase deficiency is related to the mutation of gene on human autosome 8. In this report, we detected the gene mutation sites of a 14-year-old patient with 11β-hydroxylase deficiency by whole exon sequencing (WES), verified the suspected mutation by Sanger sequencing, and analyzed its characteristics. Gene sequencing revealed that homozygous missense mutation of c.1226C>T appeared on the 8th exon of gene, which resulted in the mutation of the encoding protein Ser409 to phenylalanine (p. Ser409Phe), affecting the binding of heme and enzyme and resulting in the loss of CYP11B1 enzyme activity and a series of clinical symptoms. This mutation has not been reported at home and abroad. This case enriches the variation spectrum of gene and provides clinical data and genetic resources for further research on the pathogenesis of 11β-hydroxylase deficiency.

摘要

先天性肾上腺皮质增生症(CAH)是一种常染色体隐性遗传性疾病,11β-羟化酶缺乏症是不同类型 CAH 中第二常见的综合征。11β-羟化酶缺乏症的发生与人类常染色体 8 上基因的突变有关。本研究通过全外显子组测序(WES)检测了 1 例 11β-羟化酶缺乏症患者的基因突变位点,通过 Sanger 测序验证了可疑突变,并对其特征进行了分析。基因测序显示,基因第 8 外显子上出现 c.1226C>T 纯合错义突变,导致编码蛋白丝氨酸 409 突变为苯丙氨酸(p. Ser409Phe),影响血红素与酶的结合,导致 CYP11B1 酶活性丧失及一系列临床症状。该突变国内外尚未见报道。该病例丰富了基因的变异谱,为进一步研究 11β-羟化酶缺乏症的发病机制提供了临床数据和遗传资源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验